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  Platelet	   rich	   plasma	   (PRP),	   a	   cocktail	   of	   platelet	   growth	   factors	   and	   bio-­‐active	  proteins,	  has	  been	  proposed	  as	   therapeutic	   agent	   to	   restore	  damaged	  articular	  cartilage.	   We	   report	   the	   biological	   effect	   of	   the	   platelet	   lysate	   (PL),	   a	   PRP	  derivative,	  on	  primary	  human	  articular	  chondrocytes	  (HAC)	  cultured	  under	  both	  physiological	   and	   inflammatory	   condition.	   Added	   to	   the	   culture	   medium,	   PL	  induced	  a	  strong	  mitogenic	  response	  in	  the	  chondrocytes.	  	  The	  in	  vitro	  expanded	  cell	   population	   maintained	   a	   chondrogenic	   re-­‐differentiation	   potential	   as	  revealed	   by	  micromass	   culture	   in	   vitro	   as	  well	   as	   in	   vivo	   as	   demonstrated	   by	  ectopic	  cartilage	  formation	  in	  nude	  mice.	  Furthermore,	  in	  chondrocytes	  cultured	  in	  the	  presence	  of	  the	  pro-­‐inflammatory	  cytokine	  IL-­‐1α,	  the	  PL	  induced	  a	  drastic	  enhancement	   of	   the	   synthesis	   of	   the	   cytokines	   IL-­‐6	   and	   IL-­‐8	   and	   of	   NGAL,	   a	  lipocalin	   expressed	   in	   cells	   of	   the	   chondrogenic	   lineage.	   These	   events	   were	  controlled	  by	  the	  p38	  MAP	  kinase	  and	  NF-­‐κΒ	  pathways.	   	  The	  pro-­‐inflammatory	  effect	   of	   the	   PL	   was	   a	   transient	   phenomenon.	   In	   fact,	   after	   an	   initial	   up	  regulation,	   we	   observed	   a	   significant	   reduction	   of	   the	   NF-­‐κΒ	   activity	   together	  with	   the	   repression	   of	   the	   inflammatory	   enzyme	   ciclooxygenase-­‐2	   (COX-­‐2).	  	  Moreover,	   the	  medium	  of	  chondrocytes	  cultured	   in	   the	  contemporary	  presence	  of	   PL	   and	   IL-­‐1α,	   showed	   a	   significant	   enhancement	   of	   the	   chemoattractant	  activity	  versus	  untreated	  chondrocytes.	  On	  the	  whole,	  our	  findings	  support	  the	  concept	  that	  the	  platelet	  products	  have	  a	  direct	   beneficial	   effect	   on	   articular	   chondrocytes	   and	   at	   the	   same	   time	   could	  drive	   in	  sequence	  a	  transient	  activation	  and	  the	  resolution	  of	   the	   inflammatory	  process,	  thus	  providing	  a	  rational	  for	  their	  use	  as	  therapeutic	  agents	  in	  cartilage	  inflammation	  and	  damage.	  	  
